Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on health care–associated Clostridioides difficile infection - Top-Institutions - MDSpire

Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on health care–associated Clostridioides difficile infection

  • By

  • Jessica L Webster

  • Stephen Eppes

  • Brian K Lee

  • Nicole S Harrington

  • Neal D Goldstein

  • August 27, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Antimicrobial Stewardship

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Epidemiology
    • Microbiology

  • #3

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Biostatistics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Epidemiology
    • Antimicrobial Stewardship

  • #5

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Public Health
    • Infectious Diseases Epidemiology
    • Antimicrobial Stewardship

Original Source(s)

Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on health care–associated Clostridioides difficile infection

  • by Jessica L Webster, Stephen Eppes, Brian K Lee, Nicole S Harrington, Neal D Goldstein

  • August 27, 2024

Related Content

Global Practice Variation in the Management of Clostridioides difficile Infections: An International Cross-Sectional Survey of Clinicians

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Short Antibiotics Match Outcomes in Pneumonia

Only about one in ten hospitalized patients qualified for shorter therapy in a large US analysis